Prevnar, the first pneumococcal vaccine that can be used in children under 2
Wyeth-Ayerst is now marketing Prevnar, the first pneumococcal vaccine that can be used in children under 2.
These kids have the highest risk of invasive pneumococcal disease.
Prevnar is very effective and will be used for preventing pneumococcal bacteremia...meningitis...and pneumonia.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote